LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 72.52 | 84.90 | 1634 | 9214 | 0.1773 | 0.5486 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 72.52 | 84.90 | 1954 | 9214 | 0.2121 | 0.5901 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 72.52 | 84.90 | 1973 | 9214 | 0.2141 | 0.5924 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 74.22 | 84.90 | 1634 | 9343 | 0.1749 | 0.5466 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 74.22 | 84.90 | 1650 | 9343 | 0.1766 | 0.5488 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 74.22 | 84.90 | 2044 | 9343 | 0.2188 | 0.5985 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 74.22 | 84.90 | 2060 | 9343 | 0.2205 | 0.6003 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 75.93 | 84.90 | 1689 | 8970 | 0.1883 | 0.5602 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 75.93 | 84.90 | 1707 | 8970 | 0.1903 | 0.5626 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 75.93 | 84.90 | 2065 | 8970 | 0.2302 | 0.6075 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 75.93 | 84.90 | 2079 | 8970 | 0.2318 | 0.6091 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 77.64 | 84.90 | 1741 | 9245 | 0.1883 | 0.5627 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 77.64 | 84.90 | 1758 | 9245 | 0.1901 | 0.5649 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 77.64 | 84.90 | 2137 | 9245 | 0.2311 | 0.6107 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 77.64 | 84.90 | 2160 | 9245 | 0.2336 | 0.6133 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 79.34 | 84.90 | 1752 | 9051 | 0.1936 | 0.5673 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 79.34 | 84.90 | 1770 | 9051 | 0.1956 | 0.5697 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 79.34 | 84.90 | 2169 | 9051 | 0.2396 | 0.6178 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 79.34 | 84.90 | 2187 | 9051 | 0.2416 | 0.6198 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 81.05 | 84.90 | 1758 | 8863 | 0.1983 | 0.5713 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 81.05 | 84.90 | 1779 | 8863 | 0.2007 | 0.5741 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 81.05 | 84.90 | 2225 | 8863 | 0.2510 | 0.6275 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 81.05 | 84.90 | 2244 | 8863 | 0.2532 | 0.6295 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 82.75 | 84.90 | 1813 | 8621 | 0.2103 | 0.5829 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 82.75 | 84.90 | 1833 | 8621 | 0.2126 | 0.5855 | MN20160318_Q02 | F03 |